[Answered]: Case Study 3: Asthma Management with…

Case Study 3: Asthma Management with Beta2-Agonists and Inhaled Corticosteroids Scenario: Daniel Lopez, a 25-year-old college athlete, has asthma and uses albuterol (a short-acting beta2-agonist) as needed for symptom relief. Recently, he has been experiencing more frequent asthma attacks, especially during exercise, and often wakes up at night with shortness of breath. His physician prescribes fluticasone-salmeterol, a combination inhaler containing a long-acting beta2agonist (LABA) and an inhaled corticosteroid (ICS), for better long-term control. However, Daniel is concerned about potential side effects and expresses reluctance to take a daily medication. Discussion Questions: 1. Explain the differences between short-acting and long-acting beta2-agonists in asthma management and their respective roles in acute versus maintenance therapy. 2. What educational strategies could you use to convince Daniel of the importance of adherence to his new inhaler regimen? 3. How would you assess Daniel’s risk of uncontrolled asthma, and what additional interventions could be considered to optimize his asthma management?